ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BCEL Atreca Inc

0.15
0.00 (0.00%)
Apr 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.16
Ask Price 0.17
News -
Day High

Low
0.1023

52 Week Range

High
1.2642

Day Low
Company Name Stock Ticker Symbol Market Type
Atreca Inc BCEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.15 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.15 0.15
Trades Volume Avg Volume 52 Week Range
0 0 - 0.1023 - 1.2642
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.15 USD

Atreca Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.94M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Atreca News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BCEL Message Board. Create One! See More Posts on BCEL Message Board See More Message Board Posts

Historical BCEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.1780.1890.150.15594,349-0.028-15.73%
3 Months0.2820.380.150.27384431,676,969-0.132-46.81%
6 Months0.3250.44480.10230.27035135,569,231-0.175-53.85%
1 Year0.9461.26420.10230.29263342,949,034-0.796-84.14%
3 Years12.5212.730.10231.611,306,765-12.37-98.80%
5 Years19.9029.350.10232.87877,489-19.75-99.25%

Atreca Description

Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture IRC technology Atreca has an unparalleled insight into how cancer patients immune responses can drive better clinical outcomes. Atreca was founded by scientists industry experts and investors who share the vision that unlocking the immune response of todays patients is the key to creating a new generation of therapies. Atreca is looking for talented entrepreneurial people who are dedicated to making a positive impact on human health.

Your Recent History

Delayed Upgrade Clock